175 related articles for article (PubMed ID: 38791405)
1. Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.
Naber A; Demus D; Slieker RC; Nicolardi S; Beulens JWJ; Elders PJM; Lieverse AG; Sijbrands EJG; 't Hart LM; Wuhrer M; van Hoek M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791405
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein-CIII
Naber A; Demus D; Slieker R; Nicolardi S; Beulens JWJ; Elders PJM; Lieverse AG; Sijbrands EJG; 't Hart LM; Wuhrer M; van Hoek M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834292
[TBL] [Abstract][Full Text] [Related]
3. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.
Sinari S; Koska J; Hu Y; Furtado J; Jensen MK; Budoff MJ; Nedelkov D; McClelland RL; Billheimer D; Reaven P
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1560-1571. PubMed ID: 37317850
[TBL] [Abstract][Full Text] [Related]
4. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.
Hirano T; Sakaue T; Misaki A; Murayama S; Takahashi T; Okada K; Takeuchi H; Yoshino G; Adachi M
Kidney Int; 2003 Jun; 63(6):2171-7. PubMed ID: 12753304
[TBL] [Abstract][Full Text] [Related]
5. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
Hiukka A; Fruchart-Najib J; Leinonen E; Hilden H; Fruchart JC; Taskinen MR
Diabetologia; 2005 Jun; 48(6):1207-15. PubMed ID: 15864534
[TBL] [Abstract][Full Text] [Related]
6. Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry.
Demus D; Naber A; Dotz V; Jansen BC; Bladergroen MR; Nouta J; Sijbrands EJG; Van Hoek M; Nicolardi S; Wuhrer M
Front Chem; 2021; 9():678883. PubMed ID: 34026735
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice.
Takahashi T; Hirano T; Okada K; Adachi M
Metabolism; 2003 Oct; 52(10):1354-9. PubMed ID: 14564689
[TBL] [Abstract][Full Text] [Related]
8. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
9. Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
Lee SJ; Sacks FM
Am J Cardiol; 2003 Jul; 92(2):121-4. PubMed ID: 12860210
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
11. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels.
Shih DQ; Dansky HM; Fleisher M; Assmann G; Fajans SS; Stoffel M
Diabetes; 2000 May; 49(5):832-7. PubMed ID: 10905494
[TBL] [Abstract][Full Text] [Related]
12. Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies.
de la Parra Soto LG; Gutiérrez-Uribe JA; Sharma A; Ramírez-Jiménez AK
Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):295-308. PubMed ID: 34895805
[TBL] [Abstract][Full Text] [Related]
13. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
[TBL] [Abstract][Full Text] [Related]
14. Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
Pek SLT; Sum CF; Yeoh LY; Lee SBM; Tang WE; Lim SC; Tavintharan S
Metabolism; 2017 Jul; 72():75-82. PubMed ID: 28641786
[TBL] [Abstract][Full Text] [Related]
15. DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.
Ukkola O; Savolainen MJ; Salmela PI; von Dickhoff K; Kesäniemi YA
Clin Genet; 1994 Sep; 46(3):217-27. PubMed ID: 7820935
[TBL] [Abstract][Full Text] [Related]
16. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.
Reyes-Soffer G; Sztalryd C; Horenstein RB; Holleran S; Matveyenko A; Thomas T; Nandakumar R; Ngai C; Karmally W; Ginsberg HN; Ramakrishnan R; Pollin TI
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):63-72. PubMed ID: 30580564
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
[TBL] [Abstract][Full Text] [Related]
18. DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: a genetic determinant of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus.
Renard E; Dupuy AM; Monnier L; Crastes de Paulet A
Diabet Med; 1991 May; 8(4):354-60. PubMed ID: 1677323
[TBL] [Abstract][Full Text] [Related]
19. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
[TBL] [Abstract][Full Text] [Related]
20. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.
Xu CF; Nanjee MN; Savill J; Talmud PJ; Angelico F; Del Ben M; Antonini R; Mazzarella B; Miller N; Humphries SE
Am J Hum Genet; 1990 Sep; 47(3):429-39. PubMed ID: 1975478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
